Our study demonstrated that hepatic RORα, in cooperation with MED23, plays a role in inflammatory responses, acting as a positive regulator of CCL5 and CXCL10 in initiating the liver fibrosis, which suggests new molecular targets for clinical intervention in liver fibrosis. This evidence concerns the gene CCL5 and Hepatic fibrosis.